ABOUT THE LAB
The Polverino translational laboratory focuses on understanding the pathobiology underlying chronic obstructive pulmonary disease (COPD). COPD is the third leading cause of death both in the USA and globally. The most common risk factor in developed countries is cigarette smoke, while in developing countries, the inhalation of smoke generated by burning biomass fuels indoors is an important risk factor. COPD has a multifactorial nature, being determined not only by environmental, but also genetic, genomic, and developmental factors, which accounts for an individual susceptibility to develop the disease. In the era of precision medicine, our ultimate goal is to understand key factors in the pathogenesis of COPD to be targeted in a selected subset of COPD patients. Our laboratory is also testing the efficacy of new therapeutics in pre-clinical animal models of these diseases.
WHAT WE FOCUS ON
the key molecular and cellular culprits in the pathogenesis of COPD
genetic and genomic factors which determine the individual susceptibility to develop COPD
the immune mechanisms underlying COPD
cellular and molecular readouts with COPD clinical phenotypes
The Polverino Laboratory is funded by the Baylor College of Medicine, Pulmonary Division seed funds, and NIH/NHLBI RO1-HL149744, VICTORY Houston donations, Boehringer Ingelheim unrestricted funds, and Lester and Sue Smith endowment funds.